Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.

Maurer E, Hörtnagl C, Lackner M, Grässle D, Naschberger V, Moser P, Segal E, Semis M, Lass-Flörl C, Binder U.

Med Mycol. 2019 Apr 1;57(3):351-362. doi: 10.1093/mmy/myy042.

2.

[Social cognition in patients with mood disorders: part I: major depressive disorder : a comprehensive review of the literature].

Hörtnagl CM, Oberheinricher S, Hofer A.

Neuropsychiatr. 2014;28(2):74-83. doi: 10.1007/s40211-014-0108-8. Epub 2014 Jun 11. Review. German.

PMID:
24915903
3.

Virulence and thrombocyte affectation of two Aspergillus terreus isolates differing in amphotericin B susceptibility.

Speth C, Blum G, Hagleitner M, Hörtnagl C, Pfaller K, Posch B, Ott HW, Würzner R, Lass-Flörl C, Rambach G.

Med Microbiol Immunol. 2013 Oct;202(5):379-89. doi: 10.1007/s00430-013-0300-7. Epub 2013 May 31.

PMID:
23722593
4.

New insight into amphotericin B resistance in Aspergillus terreus.

Blum G, Hörtnagl C, Jukic E, Erbeznik T, Pümpel T, Dietrich H, Nagl M, Speth C, Rambach G, Lass-Flörl C.

Antimicrob Agents Chemother. 2013 Apr;57(4):1583-8. doi: 10.1128/AAC.01283-12. Epub 2013 Jan 14.

5.

Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers.

Walpoth-Niederwanger M, Kemmler G, Grunze H, Weiss U, Hörtnagl C, Strauss R, Blasko I, Hausmann A.

Int Clin Psychopharmacol. 2012 Sep;27(5):256-66. doi: 10.1097/YIC.0b013e328356ac92.

PMID:
22842799
6.

Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging.

Petrik M, Franssen GM, Haas H, Laverman P, Hörtnagl C, Schrettl M, Helbok A, Lass-Flörl C, Decristoforo C.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1175-83. doi: 10.1007/s00259-012-2110-3. Epub 2012 Apr 24.

7.

[Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part III. The alternatives!].

Hausmann A, Fuchs M, Walpoth M, Hörtnagl C, Adami P, Conca A.

Neuropsychiatr. 2007;21(4):248-60. Review. German.

PMID:
18082106
8.

[Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part II: facts or artefacts?].

Hausmann A, Hörtnagl C, Walpoth M, Fuchs M, Conca A.

Neuropsychiatr. 2007;21(2):131-58. Review. German.

PMID:
17640499
9.

[Psychotherapeutic interventions in bipolar disorder: a review].

Hausmann A, Hörtnagl C, Müller M, Waack J, Walpath M, Conca A.

Neuropsychiatr. 2007;21(2):102-9. Review. German.

PMID:
17640496

Supplemental Content

Loading ...
Support Center